PLAU and head and neck squamous cell carcinoma: The reported results point out that the components of the PA system uPA, uPAR and SERPINE1 could be good targets for HNSCC therapy, so that their inhibition could represent a relevant strategy to increase the efficacy of current antitumor agents.